Wound Care (Pharmacies) - Central & Western Europe

  • Central & Western Europe
  • Revenue in the Wound Care market is projected to reach US$0.42bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.59%, resulting in a market volume of US$0.43bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.26 are generated in 2024.

Key regions: South Korea, United States, Canada, United Kingdom, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Central & Western Europe is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the region are shifting towards more advanced wound care products available in pharmacies. Customers are increasingly seeking products that offer faster healing, reduced pain, and improved convenience. This has led to a growing demand for innovative wound care solutions such as advanced dressings, wound closure devices, and antimicrobial products. Customers are also becoming more conscious about the quality and efficacy of the products they purchase, driving them to choose trusted brands available in pharmacies. Trends in the market indicate a growing focus on wound care management and prevention. Healthcare professionals are emphasizing the importance of early intervention and proper wound care techniques to prevent complications and promote faster healing. This has led to an increased adoption of wound care products in pharmacies, as they offer convenient access to a wide range of wound care solutions. Additionally, there is a rising trend of self-care among individuals, who are taking proactive measures to manage their wounds and prevent infections. Local special circumstances in Central & Western Europe are contributing to the growth of the wound care market. The region has a large aging population, which is more prone to chronic wounds such as pressure ulcers and diabetic foot ulcers. This demographic trend has created a significant demand for wound care products in pharmacies, as individuals seek effective solutions to manage their chronic wounds. Furthermore, the region has a well-established healthcare infrastructure and a high level of healthcare expenditure, which supports the availability and accessibility of wound care products in pharmacies. Underlying macroeconomic factors such as increasing healthcare expenditure, technological advancements, and favorable government policies are driving the growth of the wound care market in Central & Western Europe. Governments are investing in healthcare infrastructure and promoting the use of advanced wound care products to reduce healthcare costs and improve patient outcomes. Technological advancements in wound care products, such as the development of smart dressings and bioactive materials, are also driving market growth by offering innovative solutions for wound management. Additionally, the region's strong economic growth and high disposable income levels are enabling individuals to afford and access a wide range of wound care products from pharmacies. Overall, the Wound Care (Pharmacies) market in Central & Western Europe is developing rapidly due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as customers increasingly prioritize effective wound care solutions and healthcare professionals focus on wound care management and prevention.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)